Yang Qinfeng, Liu Guihua, Chen Guanghao, Chen Guo, Chen Keyu, Fan Lei, Tu Yuesheng, Chen Jialan, Shi Zhanjun, Chen Chuan, Liu Shubo, Deng Geyang, Deng Xiaoqian, Sun Chunhan, Li Xiaoyang, Yang Shuofei, Zheng Shaowei, Chen Bin
Division of Orthopaedics and Traumatology, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Division of Orthopaedic Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Bioact Mater. 2024 Aug 29;42:85-111. doi: 10.1016/j.bioactmat.2024.08.018. eCollection 2024 Dec.
Hemophilic articular cartilage damage presents a significant challenge for surgeons, characterized by recurrent intraarticular bleeding, a severe inflammatory microenvironment, and limited self-repair capability of cartilage tissue. Currently, there is a lack of tissue engineering-based integrated therapies that address both early hemostasis, anti-inflammation, and long-lasting chondrogenesis for hemophilic articular cartilage defects. Herein, we developed an adhesive hydrogel using oxidized chondroitin sulfate and gelatin, loaded with exosomes derived from bone marrow stem cells (BMSCs) (Hydrogel-Exos). This hydrogel demonstrated favorable injectability, self-healing, biocompatibility, biodegradability, swelling, frictional and mechanical properties, providing a comprehensive approach to treating hemophilic articular cartilage defects. The adhesive hydrogel, featuring dynamic Schiff base bonds and hydrogen bonds, exhibited excellent wet tissue adhesiveness and hemostatic properties. In a pig model, the hydrogel could be smoothly injected into the knee joint cartilage defect site and gelled under fluid-irrigated arthroscopic conditions. Our and experiments confirmed that the sustained release of exosomes yielded anti-inflammatory effects by modulating macrophage M2 polarization through the NF-κB pathway. This immunoregulatory effect, coupled with the extracellular matrix components provided by the adhesive hydrogel, enhanced chondrogenesis, promoted the cartilage repair and joint function restoration after hemophilic articular cartilage defects. In conclusion, our results highlight the significant application potential of Hydrogel-Exos for early hemostasis, immunoregulation, and long-term chondrogenesis in hemophilic patients with cartilage injuries. This innovative approach is well-suited for application during arthroscopic procedures, offering a promising solution for addressing the complex challenges associated with hemophilic articular cartilage damage.
血友病性关节软骨损伤给外科医生带来了重大挑战,其特点是关节内反复出血、严重的炎症微环境以及软骨组织自我修复能力有限。目前,缺乏基于组织工程的综合疗法来解决血友病性关节软骨缺损的早期止血、抗炎和长期软骨形成问题。在此,我们使用氧化硫酸软骨素和明胶开发了一种粘性水凝胶,并负载了源自骨髓干细胞(BMSCs)的外泌体(水凝胶-外泌体)。这种水凝胶具有良好的可注射性、自愈性、生物相容性、生物降解性、膨胀性、摩擦和机械性能,为治疗血友病性关节软骨缺损提供了一种综合方法。这种具有动态席夫碱键和氢键的粘性水凝胶表现出优异的湿组织粘附性和止血性能。在猪模型中,该水凝胶可以顺利注射到膝关节软骨缺损部位,并在液体冲洗的关节镜条件下凝胶化。我们的实验证实,外泌体的持续释放通过NF-κB途径调节巨噬细胞M2极化产生抗炎作用。这种免疫调节作用,加上粘性水凝胶提供的细胞外基质成分,增强了软骨形成,促进了血友病性关节软骨缺损后的软骨修复和关节功能恢复。总之,我们的结果突出了水凝胶-外泌体在血友病性软骨损伤患者早期止血、免疫调节和长期软骨形成方面的显著应用潜力。这种创新方法非常适合在关节镜手术中应用,为解决与血友病性关节软骨损伤相关的复杂挑战提供了一个有前景的解决方案。